Ogorek Anthony Joseph’s Repligen RGEN Stock Holding History

Ogorek Anthony Joseph’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25	Closed	-$4K	–	283
2023 Q1	$4K	Buy	+25	New	+$4.46K	﹤0.01%	227

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ogorek Anthony Joseph's RGEN Position: Q2 2023 in Review

Ogorek Anthony Joseph sold out of Repligen (RGEN) in Q2 2023, closing a stake of 25 shares — an estimated $4K sold.

Ogorek Anthony Joseph first reported a position in RGEN in Q1 2023 and held it in 1 quarter. The position peaked at $4K in Q1 2023. 447 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

Ogorek Anthony Joseph reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
Ogorek Anthony Joseph sold 25 Repligen shares in Q2 2023, an estimated $4K.
Ogorek Anthony Joseph first reported a position in Repligen in Q1 2023 and held it in 1 quarter.
Ogorek Anthony Joseph's Repligen position peaked at $4K in Q1 2023.
447 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2023, filed 3 Aug 2023.